Symbol Lookup

Saturday February 28, 2015 1:53 PM ET. Data delayed 15 minutes.
11.48
0.12 (1.06%)
Bid/Lots
11.46/8
Ask/Lots
11.48/14
Open/Prev Close
11.40/11.36
Day Range
11.15-11.50
52-Week Range
4.40-12.87
Vol/Avg Daily Vol
112.3K/210.5K
  • TSX Comp
  • TSX Venture
  • DJIA
  • S&P 500
  • NASDAQ
Price Comparison Chart
Data delayed at least 15 minutes.

Recent News»

0 New Today
CytoSorbents Announces FDA Approval to Commence Initial U.S. Cardiac Surgery Study
7:00AM ET on Monday Feb 02, 2015 by PR Newswire

CytoSorbents Corporation (NASDAQ CM: CTSO), a critical care immunotherapy company commercializing its CytoSorb(R) extracorporeal cytokine adsorber to treat critically-ill and cardiac surgery patients in multiple countries worldwide, announced t...

CytoSorbents And Aferetica Introduce CytoSorb(R) to Italy
7:00AM ET on Friday Jan 30, 2015 by PR Newswire

CytoSorbents Corporation (NASDAQ CM: CTSO), a critical care immunotherapy company commercializing its CytoSorb(R) extracorporeal cytokine adsorber to treat critically-ill patients and cardiac surgery patients in multiple countries worldwide, an...

Company Information

CytoSorbents Corporation is a development stage critical care focused immunotherapy company using blood purification to modulate inflammation to preventing or treating multiple organ failure in life-threatening illnesses. The technology is based upon biocompatible, highly porous polymer sorbent beads that are capable of extracting unwanted substances, such as drugs, dangerous chemicals, toxins, cytokines, free hemoglobin, and antibodies, from blood and other bodily fluids. In addition to CytoSorb, the Company is developing other products utilizing its adsorbent polymer technology that have not received regulatory approval including HemoDefend, ContrastSorb, DrugSorb, BetaSorb and others.

CONTACT INFORMATION

Headquarters7 Deerpark Dr Ste K
MONMOUTH JUNCTION, NJ, United States 08852-1921
Phone732-329-8885
Fax732-329-8650

EXECUTIVE OFFICERS

Chairman of the BoardAl Kraus
President, Chief Executive Officer, DirectorPhillip Chan
Chief Financial OfficerKathleen Bloch
Chief Operating OfficerVincent Capponi
Chief Medical OfficerRobert Bartlett

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

Stocks Ratings Sample

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

  •  
  • INK Company Insider

    Detailed daily analysis of insider activity and holdings for stocks and income trusts listed in Canada, based on filings from SEDI®

  • S&P Capital IQ Stock Report

    S&P Capital IQ's analysts' overview and valuation, with key fundamental, quantitative, and technical analysis.

  • TDSI Morning Action Notes

    Morning Institutional Report of company updates and new recommendations.

Market Cap$281.4MBeta0.53
Revenue (TTM)$4.1MEPS$-0.82
Shares Out.24.5MBook Value$0.10
Dividend Yield0.00%P/E--
Annual Dividend Rate$0.00Price/Sales (TTM)68.2
Ex-Div Date1/1/01P/Cash Flow (TTM)--
Pay Date1/1/01Operating Margin-126.64%

*GAAP = prior to non-GAAP analyst adjusted earnings.

(Non-GAAP)*

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.

Stocks Calendar Sample